Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Medecine Sciences : M/S
|
November 18, 2024
[Metabolic dysfunctions in type I myotonic dystrophy: A potential therapeutic target]
Lola Lessard, Laure Gallay, Rémi Mounier
Current Opinion in Rheumatology
|
September 22, 2018
Antisynthetase syndrome pathogenesis: knowledge and uncertainties
Laure Gallay, Catherine Gayed, Baptiste Hervier
Current Opinion in Rheumatology
|
August 30, 2019
Interferon-signature in idiopathic inflammatory myopathies
Laure Gallay, Guy Mouchiroud, Bénédicte Chazaud
Neuromuscular Disorders : NMD
|
January 4, 2022
Idiopathic eosinophilic myositis: a systematic literature review
Cécile Fermon, François-Jérôme Authier, Laure Gallay
Best Practice & Research. Clinical Rheumatology
|
November 10, 2025
Emerging therapies in idiopathic inflammatory myopathies: Advances in treatment and future directions
Laure Gallay, Eaman Alhassan, Niladri Bhowmick, et al.
Seminars in Arthritis and Rheumatism
|
May 21, 2023
Joint and muscle inflammatory disease: A scoping review of the published evidence
Maud Lekieffre, Laure Gallay, Océane Landon-Cardinal, et al.
Neuromuscular Disorders : NMD
|
September 18, 2016
SWORD: A simplified desensitization protocol for enzyme replacement therapy in adult Pompe disease
Laure Gallay, Philippe Petiot, Isabelle Durieu, et al.
Neurology
|
February 23, 2018
Focal myositis: New insights on diagnosis and pathology
Laure Gallay, Arnaud Hot, Philippe Petiot, et al.
Neuromuscular Disorders : NMD
|
November 3, 2024
273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023
Werner Stenzel, Andrew L Mammen, Laure Gallay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 5, 2021
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study
Laure Gallay, Viet-Thi Tran, Elodie Perrodeau, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Medecine Sciences : M/S
|
November 18, 2024
[Metabolic dysfunctions in type I myotonic dystrophy: A potential therapeutic target]
Lola Lessard, Laure Gallay, Rémi Mounier
Current Opinion in Rheumatology
|
September 22, 2018
Antisynthetase syndrome pathogenesis: knowledge and uncertainties
Laure Gallay, Catherine Gayed, Baptiste Hervier
Current Opinion in Rheumatology
|
August 30, 2019
Interferon-signature in idiopathic inflammatory myopathies
Laure Gallay, Guy Mouchiroud, Bénédicte Chazaud
Neuromuscular Disorders : NMD
|
January 4, 2022
Idiopathic eosinophilic myositis: a systematic literature review
Cécile Fermon, François-Jérôme Authier, Laure Gallay
Best Practice & Research. Clinical Rheumatology
|
November 10, 2025
Emerging therapies in idiopathic inflammatory myopathies: Advances in treatment and future directions
Laure Gallay, Eaman Alhassan, Niladri Bhowmick, et al.
Seminars in Arthritis and Rheumatism
|
May 21, 2023
Joint and muscle inflammatory disease: A scoping review of the published evidence
Maud Lekieffre, Laure Gallay, Océane Landon-Cardinal, et al.
Neuromuscular Disorders : NMD
|
September 18, 2016
SWORD: A simplified desensitization protocol for enzyme replacement therapy in adult Pompe disease
Laure Gallay, Philippe Petiot, Isabelle Durieu, et al.
Neurology
|
February 23, 2018
Focal myositis: New insights on diagnosis and pathology
Laure Gallay, Arnaud Hot, Philippe Petiot, et al.
Neuromuscular Disorders : NMD
|
November 3, 2024
273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023
Werner Stenzel, Andrew L Mammen, Laure Gallay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 5, 2021
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study
Laure Gallay, Viet-Thi Tran, Elodie Perrodeau, et al.
Page
of 4